Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Napatkamon Ayutyanont; Kewei Chen; Auttawut Roontiva; Adam Fleisher; Jessica Langbaum; Cole Reschke; Wendy Lee; Xiaofen Liu; Dan Bandy; Gene Alexander; Norman Foster; Danielle Harvey; Michael Weiner; Robert Koeppe; William Jagust; Eric Reiman

doi:10.1016/J.JALZ.2011.05.150

Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Napatkamon Ayutyanont
, Kewei Chen
, Auttawut Roontiva
, Adam Fleisher
, Jessica Langbaum
, Cole Reschke
, Wendy Lee
, Xiaofen Liu
, Dan Bandy
, Gene Alexander
, Norman Foster
, Danielle Harvey
, Michael Weiner
, Robert Koeppe
, William Jagust
, Eric Reiman

Banner Alzheimer's Institute and Banner Good Samaritan PET Center, Phoenix, AZ; Arizona Alzheimer's Consortium, Phoenix, AZ, Phoenix, Arizona, United States
Arizona State University
University of California, San Diego
University of Arizona
University of Utah
University of California, Davis
University of California, San Francisco
University of Michigan
Helen Wills Neuroscience Institute
Translational Genomics Research Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Alzheimers & Dementia
Volume	7
Issue number	4
DOIs	https://doi.org/10.1016/J.JALZ.2011.05.150
State	Published - Jul 1 2011
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Gerontology
Internal Medicine

Access to Document

10.1016/J.JALZ.2011.05.150License: Unspecified

Cite this

Ayutyanont, N., Chen, K., Roontiva, A., Fleisher, A., Langbaum, J., Reschke, C., Lee, W., Liu, X., Bandy, D., Alexander, G., Foster, N., Harvey, D., Weiner, M., Koeppe, R., Jagust, W., & Reiman, E. (2011). Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers & Dementia, 7(4). https://doi.org/10.1016/J.JALZ.2011.05.150

Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI). / Ayutyanont, Napatkamon; Chen, Kewei; Roontiva, Auttawut et al.
In: Alzheimers & Dementia, Vol. 7, No. 4, 01.07.2011.

Research output: Contribution to journal › Article › peer-review

Ayutyanont, N, Chen, K, Roontiva, A, Fleisher, A, Langbaum, J, Reschke, C, Lee, W, Liu, X, Bandy, D, Alexander, G, Foster, N, Harvey, D, Weiner, M, Koeppe, R, Jagust, W & Reiman, E 2011, 'Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI)', Alzheimers & Dementia, vol. 7, no. 4. https://doi.org/10.1016/J.JALZ.2011.05.150

@article{9cfed34453bf4ebc913e5c4477b31b47,

title = "Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI)",

author = "Napatkamon Ayutyanont and Kewei Chen and Auttawut Roontiva and Adam Fleisher and Jessica Langbaum and Cole Reschke and Wendy Lee and Xiaofen Liu and Dan Bandy and Gene Alexander and Norman Foster and Danielle Harvey and Michael Weiner and Robert Koeppe and William Jagust and Eric Reiman",

note = "Ayutyanont, Napatkamon; Chen, Kewei; Roontiva, Auttawut; Fleisher, Adam; Langbaum, Jessica; Reschke, Cole; Lee, Wendy; Liu, Xiaofen; Bandy, Dan; Alexander, Gene; Foster, Norman; Harvey, Danielle; Weiner, Michael; Koeppe, Robert; Jagust, William; Reiman, Eric (2011). {"}P2‐190: Use of an FDG‐PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI).{"}",

year = "2011",

month = jul,

day = "1",

doi = "10.1016/J.JALZ.2011.05.150",

language = "American English",

volume = "7",

journal = "Alzheimers \& Dementia",

issn = "1552-5279",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

AU - Ayutyanont, Napatkamon

AU - Chen, Kewei

AU - Roontiva, Auttawut

AU - Fleisher, Adam

AU - Langbaum, Jessica

AU - Reschke, Cole

AU - Lee, Wendy

AU - Liu, Xiaofen

AU - Bandy, Dan

AU - Alexander, Gene

AU - Foster, Norman

AU - Harvey, Danielle

AU - Weiner, Michael

AU - Koeppe, Robert

AU - Jagust, William

AU - Reiman, Eric

N1 - Ayutyanont, Napatkamon; Chen, Kewei; Roontiva, Auttawut; Fleisher, Adam; Langbaum, Jessica; Reschke, Cole; Lee, Wendy; Liu, Xiaofen; Bandy, Dan; Alexander, Gene; Foster, Norman; Harvey, Danielle; Weiner, Michael; Koeppe, Robert; Jagust, William; Reiman, Eric (2011). "P2‐190: Use of an FDG‐PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI)."

PY - 2011/7/1

Y1 - 2011/7/1

UR - https://deepblue.lib.umich.edu/handle/2027.42/153218

U2 - 10.1016/J.JALZ.2011.05.150

DO - 10.1016/J.JALZ.2011.05.150

M3 - Article

SN - 1552-5279

VL - 7

JO - Alzheimers & Dementia

JF - Alzheimers & Dementia

IS - 4

ER -

Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Disciplines

Access to Document

Other files and links

Cite this